- R87.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM R87.7 became effective on October 1, 2022.
- This is the American ICD-10-CM version of R87.7 – other international versions of ICD-10 R87.7 may differ.
ICD-10-CM R87.7 is grouped within Diagnostic Related Group(s):
Type 1 Excludes
- carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to R87.7:
- histological > female genital organs (secretions) (smears) R87.9